We are talking about a drug that has proven safe in over 800 HIV patients, which has shown high activity in mTNBC and colon cancer in mice and is likely to be used for metastasis in most common cancers. And now we are waiting for the set to confirm in humans, in this case in women with stage three or four particularly aggressive mTNBC.
If the CTC test works, it will be a validation of the concept for MOA for a lot of metastatic cancers, for me it is very much.